Literature DB >> 21871481

Null misinterpretation in statistical testing and its impact on health risk assessment.

Sander Greenland1.   

Abstract

Statistical methods play a pivotal role in health risk assessment, but not always an enlightened one. Problems well known to academics are frequently overlooked in crucial nonacademic venues such as litigation, even though those venues can have profound impacts on population health and medical practice. Statisticians have focused heavily on how statistical significance overstates evidence against null hypotheses, but less on how statistical nonsignificance does not correspond to evidence for the null. I thus present an example of a highly credentialed statistical expert conflating high "nonsignificance" with strong support for the null, via misinterpretation of a P-value as a posterior probability of the null hypothesis. Reverse-Bayes analyses reveal that nearly all the support for the null claimed by the expert must have come from the expert's prior, rather than the data, there being no background data that could support a strong prior. The example illustrates how inattention to the actual meaning of P-values and confidence limits allow extremely biased prior opinions (including null-spiked opinions) to be presented as if they were objective inferences from the data. Copyright Â
© 2011. Published by Elsevier Inc.

Mesh:

Year:  2011        PMID: 21871481     DOI: 10.1016/j.ypmed.2011.08.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  The researcher and the consultant: a dialogue on null hypothesis significance testing.

Authors:  Andreas Stang; Charles Poole
Journal:  Eur J Epidemiol       Date:  2013-12       Impact factor: 8.082

2.  For and Against Methodologies: Some Perspectives on Recent Causal and Statistical Inference Debates.

Authors:  Sander Greenland
Journal:  Eur J Epidemiol       Date:  2017-02-20       Impact factor: 8.082

3.  The limits of p-values for biological data mining.

Authors:  James D Malley; Abhijit Dasgupta; Jason H Moore
Journal:  BioData Min       Date:  2013-05-11       Impact factor: 2.522

4.  Perioperative haemodynamic therapy for major gastrointestinal surgery: the effect of a Bayesian approach to interpreting the findings of a randomised controlled trial.

Authors:  Elizabeth G Ryan; Ewen M Harrison; Rupert M Pearse; Simon Gates
Journal:  BMJ Open       Date:  2019-03-07       Impact factor: 2.692

5.  Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance.

Authors:  Triet H Tran; Joan E Steffen; Kate M Clancy; Tess Bird; David S Egilman
Journal:  Epidemiology       Date:  2019-11       Impact factor: 4.822

Review 6.  To test or to estimate? P-values versus effect sizes.

Authors:  Daniela Dunkler; Maria Haller; Rainer Oberbauer; Georg Heinze
Journal:  Transpl Int       Date:  2019-10-21       Impact factor: 3.782

Review 7.  Reverse-Bayes methods for evidence assessment and research synthesis.

Authors:  Leonhard Held; Robert Matthews; Manuela Ott; Samuel Pawel
Journal:  Res Synth Methods       Date:  2021-12-30       Impact factor: 9.308

8.  Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.

Authors:  Sander Greenland; Stephen J Senn; Kenneth J Rothman; John B Carlin; Charles Poole; Steven N Goodman; Douglas G Altman
Journal:  Eur J Epidemiol       Date:  2016-05-21       Impact factor: 8.082

9.  Beyond 'significance': principles and practice of the Analysis of Credibility.

Authors:  Robert A J Matthews
Journal:  R Soc Open Sci       Date:  2018-01-17       Impact factor: 2.963

10.  Reporting and interpretation of results from clinical trials that did not claim a treatment difference: survey of four general medical journals.

Authors:  Simon Gates; Elizabeth Ealing
Journal:  BMJ Open       Date:  2019-09-08       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.